Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,686,669
-$10,490,587 QoQ
Shares Held
70,061
-45.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#77
of 307 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. ASND ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
6,845,276 | $322,001,783 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
959,048 | $321,079,679 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
4,418,557 | $266,704,100 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,799,166 | $248,509,957 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
6,463,551 | $241,866,078 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
1,740,101 | $230,963,605 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
4,728,623 | $192,123,952 | |
| 8 | SEPN |
Septerna, Inc.
|
4,433,058 | $148,463,112 |
All Filings in ASND
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,686,669 | 70,061 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,177,256 | 127,562 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,323,441 | 156,272 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,620,390 | 179,168 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,675,640 | 195,108 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,664,067 | 151,829 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,183,244 | 88,496 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,068,223 | 114,314 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,100,786 | 81,396 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $15,165,374 | 100,320 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $19,324,689 | 180,234 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,011,123 | 180,227 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,736,088 | 123,340 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,782,929 | 137,510 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,177,582 | 129,325 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,930,024 | 81,246 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,934,020 | 81,147 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,397,451 | 56,233 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,751,894 | 52,389 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,740,889 | 184,320 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $25,478,386 | 165,101 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,554,805 | 186,307 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $18,608,126 | 165,244 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||